FindTrial
Sign In

Methods of controlling symptoms of temporomandibular dysfunction and bruxism

Effectives of different methods os interventions in TMD symptoms and Brussels - Randomized Clinical Trial - not applicable: not applicable

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-98dxv3
Enrollment
Unknown
Registered
2020-02-27
Start date
2019-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bruxism

Interventions

Will be selected 66 possible bruxists with symptoms of temporomandibular dysfunction (TMD) who will answer the bruxism questionnaires reported based on the diagnostic criteria of the American Academy
Behavioural
E05.318.308.980
L01.224.900.685
J01.897.280.500

Sponsors

Juliane Dias de Oliveira
Lead Sponsor
Juliane Dias de Oliveira
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women will be included in the sample; older than 18 years; TMD symptomatology; bruxism reported and possessing smartphone.

Exclusion criteria

Exclusion criteria: Use of painkillers; antiinflammatories; botulinum toxin; myorelaxant plate for TMD treatment; in orthodontic treatment; who only have a diagnosis of bruxism or TMD.

Design outcomes

Primary

MeasureTime frame
Investigate the effectiveness of No Clenthing App and a video information to control TMD symptoms associated to possible bruxism. It is expected to find a decrease in TMD symptoms and severity according Diagnostic Criteria for Temporomandibular Disorders (DC / TMD), ProDTM Multi questionnaire and the Pain-Related Surveillance and Awareness questionnaire (PVAQ). Considering at least 5% variation in pre and post intervention measurements.—

Secondary

MeasureTime frame
Secondary outcomes are not expected.—

Countries

Brazil

Contacts

Public ContactJuliane;Viviane Oliveira;Degan

Fundação Hermínio Ometto;Fundação Hermínio Ometto

julianedias88@gmail.com;vivianedegan@fho.edu.br5508396444856;5519984010053

Outcome results

None listed

Source: REBEC (via WHO ICTRP)